COMMUNIQUÉS West-GlobeNewswire

Quantum Cyber (f/k/a Mainz Biomed) Announces Stock Ticker Symbol Change to NASDAQ: QUCY
13/03/2026
BERKELEY, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: QUCY) doing business as Quantum Cyber, today announced, effective upon the commencement of trading on March 12, 2026 (U.S. Eastern Time), [...]
XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation
13/03/2026
Your vote is important – Vote well in advance of the proxy voting deadline: March 20, 2026 XORTX’s board of directors unanimously recommends that Shareholders vote FOR all resolutions Shareholder questions or need [...]
Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD
13/03/2026
Over 22 million Americans are diagnosed with ADHD — yet an objective biological marker for distinguishing between its three distinct subtypes has, to date, remained elusive 1 Firefly’s AI-powered EEG/ERP technology may [...]
Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
13/03/2026
Innovative non-hallucinogenic approach combines MEAI with Palmitoylethanolamide to tackle major depressive disorder, addressing a surging market expected to surpass $25 billion by 2030 Vancouver, Canada, March 13, 2026 [...]
Bladder Cancer Patients Report Delayed Diagnosis and Gaps in Support
13/03/2026
National BCAN report highlights diagnostic delays, mental health gaps and financial strain Bethesda, MD, March 13, 2026 (GLOBE NEWSWIRE) -- A new national survey from the Bladder Cancer Advocacy Network (BCAN) finds [...]
Picard Medical / SynCardia Highlight Total Artificial Heart on BTV Program Airing on FOX Business News
13/03/2026
Segment showcases SynCardia Total Artificial Heart supporting patients with advanced heart failure and next-generation development programs TUCSON, Ariz., March 13, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE [...]
Novonesis issues EUR 1.7 billion senior unsecured notes
13/03/2026
On March 12, 2026, Novonesis, through Novozymes A/S, successfully priced and closed an aggregate principal amount of EUR 1.7 billion senior unsecured notes (the "Notes"). The issuance was completed under the newly [...]
IBA Notice of Full Year 2025 Results and Conference Call
13/03/2026
FY25 results webcast to take place on Friday, 27 March 2026 at 3pm CET Louvain-la-Neuve, Belgium, 13 March 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, [...]
IBA : Publication des résultats annuels 2025 et conférence web
13/03/2026
La conférence sur les résultats de l’exercice 2025 aura lieu le vendredi 27 mars 2026 à 15h00, heure de Bruxelles Louvain-la-Neuve, Belgique, le 13 mars 2026 - IBA (Ion Beam Applications S.A le leader mondial des [...]
Now Available: Fresh Bloom THCA Flower Subscription Box by The Hemp Doctor
13/03/2026
MOORESVILLE, N.C., March 13, 2026 (GLOBE NEWSWIRE) -- The Hemp Doctor introduces the Fresh Bloom THCA Flower Subscription Box , a monthly drop of hand-selected flower and pre-rolls delivered to your door, including [...]
Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results
13/03/2026
VICTORIA, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary [...]
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering
13/03/2026
RICHMOND, Va., March 12, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced the pricing of its offering of $450,000,000 aggregate principal amount of 0.625% convertible senior notes [...]
IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026
12/03/2026
Presented updated glioblastoma (“GBM”) data demonstrating durable survival and a favorable safety profile across Phase 1 and Phase 2 programs, with repeat dosing of DeltEx™ Drug-Resistant Immunotherapy γδ T cells (“DRI [...]
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
12/03/2026
Deramiocel BLA for Duchenne muscular dystrophy under U.S. FDA review with PDUFA target action date of August 22, 2026 Pivotal HOPE-3 Phase 3 trial achieved primary endpoint (PUL v2.0) and key secondary cardiac endpoint [...]
OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
12/03/2026
-- Data from the ongoing PIKture-01 trial is expected to be announced in March 2026 ; continued enrollment in breast cancer triplet combinations -- Next-generation PI3K α pan-mutant inhibitor development candidate for [...]
The Ensign Group to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026
12/03/2026
SAN JUAN CAPISTRANO, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign ™ group of companies, which invest in and provide skilled nursing and senior living [...]
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026
12/03/2026
Conference Call Scheduled for Thursday, March 26, 2026, at 4:30 pm ET SARATOGA, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing [...]
Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results
12/03/2026
Full-Year Net Revenue Increased 33% Y-O-Y to $18.8 Million and Fourth-Quarter Net Revenue up 22% Y-O-Y to $4.7 Million Reports Second Consecutive Year of Positive Net Income SOUTH ORANGE, N.J., March 12, 2026 (GLOBE [...]
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
12/03/2026
VANCOUVER, British Columbia and BOSTON, MA, March 12, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical [...]

Pages